loading
Schlusskurs vom Vortag:
$6.36
Offen:
$6.46
24-Stunden-Volumen:
570.11K
Relative Volume:
0.41
Marktkapitalisierung:
$369.01M
Einnahmen:
$217.11M
Nettoeinkommen (Verlust:
$-651.19M
KGV:
-9.2924
EPS:
-0.71
Netto-Cashflow:
$-387.26M
1W Leistung:
-9.78%
1M Leistung:
-26.07%
6M Leistung:
-77.45%
1J Leistung:
-88.47%
1-Tages-Spanne:
Value
$6.26
$6.70
1-Wochen-Bereich:
Value
$6.01
$7.21
52-Wochen-Spanne:
Value
$5.26
$75.20

Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile

Name
Firmenname
Ginkgo Bioworks Holdings Inc
Name
Telefon
(877) 442-5362
Name
Adresse
27 DRYDOCK AVENUE, BOSTON
Name
Mitarbeiter
1,218
Name
Twitter
Name
Nächster Verdiensttermin
2024-08-08
Name
Neueste SEC-Einreichungen
Name
DNA's Discussions on Twitter

Vergleichen Sie DNA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
DNA 6.58 369.01M 217.11M -651.19M -387.26M -0.71
VRTX 449.14 115.43B 10.63B -479.80M -1.35B 13.33
REGN 748.83 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 587.39 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 248.01 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 106.99 24.89B 3.30B -501.07M 1.03B 11.54

Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-05-15 Herabstufung BTIG Research Neutral → Sell
2024-05-10 Herabstufung William Blair Mkt Perform → Underperform
2023-11-14 Herabstufung Raymond James Outperform → Mkt Perform
2023-11-09 Herabstufung BTIG Research Buy → Neutral
2023-06-02 Herabstufung Goldman Neutral → Sell
2023-05-11 Herabstufung William Blair Outperform → Mkt Perform
2022-11-29 Eingeleitet Berenberg Buy
2022-10-04 Eingeleitet Morgan Stanley Equal-Weight
2022-05-18 Herabstufung BofA Securities Neutral → Underperform
2022-03-02 Fortgesetzt Cowen Outperform
2022-02-23 Eingeleitet Goldman Neutral
2022-02-01 Eingeleitet BofA Securities Neutral
2022-01-28 Eingeleitet BofA Securities Buy
2022-01-07 Eingeleitet BTIG Research Buy
2021-11-29 Eingeleitet Jefferies Buy
2021-10-13 Eingeleitet Raymond James Outperform
2021-10-12 Eingeleitet William Blair Outperform
2021-09-20 Eingeleitet HSBC Securities Buy
Alle ansehen

Ginkgo Bioworks Holdings Inc Aktie (DNA) Neueste Nachrichten

pulisher
Nov 20, 2024

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by Tao Capital Management LP - MarketBeat

Nov 20, 2024
pulisher
Nov 19, 2024

US Bancorp DE Sells 183,450 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

How To Trade (DNA) - Stock Traders Daily

Nov 18, 2024
pulisher
Nov 18, 2024

Ginkgo Bioworks: Unproven Transition But 2025 Is Looking Better (NYSE:DNA) - Seeking Alpha

Nov 18, 2024
pulisher
Nov 18, 2024

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Short Interest Update - MarketBeat

Nov 18, 2024
pulisher
Nov 16, 2024

GSA Capital Partners LLP Has $979,000 Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Nov 16, 2024
pulisher
Nov 15, 2024

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Just Released Its Third-Quarter Earnings: Here's What Analysts Think - Simply Wall St

Nov 15, 2024
pulisher
Nov 15, 2024

Ginkgo Bioworks Holdings Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 15, 2024
pulisher
Nov 13, 2024

Ginkgo cancels move to new South Boston lab, exits Cambridge office - MassLive.com

Nov 13, 2024
pulisher
Nov 13, 2024

Ginkgo Bioworks Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024
pulisher
Nov 13, 2024

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q3 2024 Earnings Call Transcript - MSN

Nov 13, 2024
pulisher
Nov 13, 2024

Ginkgo Bioworks: Not Enough Progress (NYSE:DNA) - Seeking Alpha

Nov 13, 2024
pulisher
Nov 13, 2024

Baillie Gifford & Co. Sells 131,067,285 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Nov 13, 2024
pulisher
Nov 12, 2024

Ginkgo Bioworks Reports Q3 Growth and Strategic Deals - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Ginkgo nixes move to South Boston lab, will exit Cambridge sites. Here's what it means - NBC Boston

Nov 12, 2024
pulisher
Nov 12, 2024

Ginkgo nixes move to South Boston lab, will exit Cambridge sites - The Business Journals

Nov 12, 2024
pulisher
Nov 12, 2024

Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 12, 2024
pulisher
Nov 12, 2024

Ginkgo Bioworks Reports Third Quarter 2024 Financial Results – Company Announcement - Financial Times

Nov 12, 2024
pulisher
Nov 12, 2024

Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing - Marketscreener.com

Nov 12, 2024
pulisher
Nov 12, 2024

Ginkgo Bioworks Secures $9M Milestone Payment from Merck Partnership Breakthrough | DNA Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

Insights into Ginkgo Bioworks Holdings's Upcoming Earnings - Benzinga

Nov 11, 2024
pulisher
Nov 08, 2024

Ginkgo Bioworks chief accounting officer sells $2,522 in stock - Investing.com India

Nov 08, 2024
pulisher
Nov 08, 2024

Ginkgo Bioworks chief accounting officer sells $2,522 in stock By Investing.com - Investing.com Australia

Nov 08, 2024
pulisher
Nov 08, 2024

(DNA) On The My Stocks Page - Stock Traders Daily

Nov 08, 2024
pulisher
Nov 06, 2024

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Receives Consensus Recommendation of "Reduce" from Brokerages - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

Ginkgo Bioworks (DNA) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

BTIG Downgrades Ginkgo Bioworks Holdings Inc(DNA) - MSN

Nov 06, 2024
pulisher
Nov 05, 2024

Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation - BioSpace

Nov 05, 2024
pulisher
Nov 05, 2024

Ginkgo Bioworks (DNA) Sets Q3 2024 Earnings Call for November 12 | DNA Stock News - StockTitan

Nov 05, 2024
pulisher
Nov 05, 2024

Dutch ingredients Firm Vivici Partners With Ginkgo Bioworks For Alternative Protein Development - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Reduction in Ginkgo Bioworks Holdings Inc - GuruFocus.com

Nov 05, 2024
pulisher
Nov 03, 2024

With 48% ownership, Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has piqued the interest of institutional investors - Yahoo Finance

Nov 03, 2024
pulisher
Oct 31, 2024

Ginkgo Bioworks (DNA): A Leader in Cell Programming and Genetic Diagnostics - Insider Monkey

Oct 31, 2024
pulisher
Oct 30, 2024

10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds - Insider Monkey

Oct 30, 2024
pulisher
Oct 30, 2024

Ginkgo Bioworks Holdings, Inc. (DNA) Outpaces Stock Market Gains: What You Should Know - MSN

Oct 30, 2024
pulisher
Oct 28, 2024

Forbes J M & Co. LLP Invests $1.02 Million in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Oct 28, 2024
pulisher
Oct 27, 2024

PFG Investments LLC Invests $1.54 Million in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Oct 27, 2024
pulisher
Oct 23, 2024

Major Boston biotech company begins layoffs this week - MSN

Oct 23, 2024
pulisher
Oct 22, 2024

Ginkgo Bioworks (NYSE:DNA) Shares Up 5%Here's What Happened - MarketBeat

Oct 22, 2024
pulisher
Oct 19, 2024

Equitec Proprietary Markets LLC Has $99,000 Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Oct 19, 2024
pulisher
Oct 15, 2024

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Sees Significant Growth in Short Interest - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Ginkgo Bioworks (NYSE:DNA) Trading 5.9% HigherStill a Buy? - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Exchange Traded Concepts LLC Has $2.99 Million Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Oct 15, 2024
pulisher
Oct 14, 2024

Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now? - MSN

Oct 14, 2024
pulisher
Oct 14, 2024

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by Squarepoint Ops LLC - MarketBeat

Oct 14, 2024
pulisher
Oct 13, 2024

Algert Global LLC Takes $36,000 Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Oct 13, 2024
pulisher
Oct 12, 2024

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Receives $4.16 Consensus Target Price from Analysts - MarketBeat

Oct 12, 2024
pulisher
Oct 09, 2024

Ginkgo Bioworks Holdings Inc (DNA) Q2 2024 Earnings Call Highlights: Strategic Restructuring ... By GuruFocus - Investing.com Canada

Oct 09, 2024
pulisher
Oct 08, 2024

Ginkgo Bioworks executive sells over $10k in company stock By Investing.com - Investing.com Australia

Oct 08, 2024
pulisher
Oct 08, 2024

Ginkgo Bioworks exec sells over $2500 in stock By Investing.com - Investing.com Canada

Oct 08, 2024

Finanzdaten der Ginkgo Bioworks Holdings Inc-Aktie (DNA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):